Integral Diagnostics Ltd (IDX) — Cash Flow Quality Index
Integral Diagnostics Ltd (IDX) has a Cash Flow Quality Index of 10.18x as of June 2025. Operating cash flow of AU$51.60 Million exceeds net income of AU$5.07 Million, indicating high earnings quality where cash backs reported profits. Explore IDX long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Integral Diagnostics Ltd Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Integral Diagnostics Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Integral Diagnostics Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Integral Diagnostics Ltd (2013–2025)
Year-by-year earnings quality comparison for Integral Diagnostics Ltd. For live market cap and the full company financial profile, see IDX stock market capitalisation.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 15.79x | AU$73.77 Million | AU$4.67 Million | ▲ +453.5% |
| 2023 | 2.85x | AU$71.42 Million | AU$25.04 Million | ▲ +12.3% |
| 2022 | 2.54x | AU$37.10 Million | AU$14.60 Million | ▲ +14.2% |
| 2021 | 2.23x | AU$69.57 Million | AU$31.27 Million | ▼ -5.5% |
| 2020 | 2.36x | AU$54.25 Million | AU$23.03 Million | ▲ +45.7% |
| 2019 | 1.62x | AU$33.92 Million | AU$20.98 Million | ▼ -8.1% |
| 2018 | 1.76x | AU$26.52 Million | AU$15.08 Million | ▲ +19.8% |
| 2017 | 1.47x | AU$22.73 Million | AU$15.48 Million | ▼ -30.5% |
| 2016 | 2.11x | AU$24.05 Million | AU$11.39 Million | ▼ -44.5% |
| 2015 | 3.80x | AU$17.11 Million | AU$4.50 Million | ▲ +252.3% |
| 2014 | 1.08x | AU$3.70 Million | AU$3.42 Million | ▼ -6.8% |
| 2013 | 1.16x | AU$3.74 Million | AU$3.23 Million | — |